Loading company details...
Beta
Latest Form 4 (Sep 15, 2026): Hamid Khoja (Chief Scientific Officer): Grant/Award of 298,508 shares, $500.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Hamid Khoja, Chief Scientific Officer | Grant/Award | 298,508 | $500.0K |
| Jun 24, 2026 | Robert E. Hoffman | Grant/Award | 30,803 | n/a |
| Jun 24, 2026 | Richard C. Cilento Jr. | Grant/Award | 30,803 | n/a |
| Jun 24, 2026 | Matthew Link | Grant/Award | 30,803 | n/a |
| Jun 23, 2026 | Victoria Ninon Olivia Niklas | Grant/Award | 30,803 | n/a |
| May 4, 2026 | Pete O'Heeron, CHIEF EXECUTIVE OFFICER | Grant/Award | 92,410 | n/a |
| May 4, 2026 | Hamid Khoja, Chief Scientific Officer | Grant/Award | 61,607 | n/a |
| May 4, 2026 | Jason Davis, Chief Financial Officer | Grant/Award | 61,607 | n/a |
| May 4, 2026 | Ruben A. Garcia, General Counsel | Grant/Award | 61,607 | n/a |
| Mar 5, 2026 | Hamid Khoja, Chief Scientific Officer | Purchase | 30,000 | $11.4K |